Decades-long study reveals outcomes of prenatal steroid treatment for rare genetic disorder

Researchers have published updated long-term data on prenatal dexamethasone therapy for congenital adrenal hyperplasia, a rare genetic condition affecting hormone production. The findings could reshape treatment guidelines and inform decisions for families facing this diagnosis, with implications for pharmaceutical policy and clinical practice standards.

Originaltitel: An update on the long-term outcomes of prenatal dexamethasone treatment in congenital adrenal hyperplasia